Home > > > > > Report Detail

Dysmenorrhea - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Dysmenorrhea - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Dysmenorrhea epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Dysmenorrhea Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Dysmenorrhea in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Dysmenorrhea outlook. It also includes the explanation of changing trends of epidemiology outlining the Dysmenorrhea scenario.

Dysmenorrhea Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Dysmenorrhea thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Dysmenorrhea explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Dysmenorrhea Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Dysmenorrhea

Key assessments

- Patient Segmentation in Dysmenorrhea

- Dysmenorrhea Risk & Burden

- Factors driving growth in a specific Dysmenorrhea patient population

 

Dysmenorrhea - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Dysmenorrhea Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Dysmenorrhea in 2016
2.2. Patient Share Distribution of Dysmenorrhea in 2028
3. Disease Background and Overview: Dysmenorrhea
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Dysmenorrhea in 7MM
4.3. Total Prevalent/ Incident Patient Population of Dysmenorrhea in 7MM - By Countries
5. Epidemiology of Dysmenorrhea by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Dysmenorrhea
5.1.3. Sub-Type Specific cases of the Dysmenorrhea *
5.1.4. Sex- Specific Cases of the Dysmenorrhea *
5.1.5. Diagnosed Cases of the Dysmenorrhea
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Dysmenorrhea
5.4.3. Sub-Type Specific cases of the Dysmenorrhea *
5.4.4. Sex- Specific Cases of the Dysmenorrhea *
5.4.5. Diagnosed Cases of the Dysmenorrhea
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Dysmenorrhea
5.5.3. Sub-Type Specific cases of the Dysmenorrhea *
5.5.4. Sex- Specific Cases of the Dysmenorrhea *
5.5.5. Diagnosed Cases of the Dysmenorrhea
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Dysmenorrhea
5.6.3. Sub-Type Specific cases of the Dysmenorrhea *
5.6.4. Sex- Specific Cases of the Dysmenorrhea *
5.6.5. Diagnosed Cases of the Dysmenorrhea
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Dysmenorrhea
5.7.3. Sub-Type Specific cases of the Dysmenorrhea *
5.7.4. Sex- Specific Cases of the Dysmenorrhea *
5.7.5. Diagnosed Cases of the Dysmenorrhea
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Dysmenorrhea
5.8.3. Sub-Type Specific cases of the Dysmenorrhea *
5.8.4. Sex- Specific Cases of the Dysmenorrhea *
5.8.5. Diagnosed Cases of the Dysmenorrhea
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Dysmenorrhea
5.9.3. Sub-Type Specific cases of the Dysmenorrhea *
5.9.4. Sex- Specific Cases of the Dysmenorrhea *
5.9.5. Diagnosed Cases of the Dysmenorrhea
6. Unmet Needs of the Dysmenorrhea
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Dysmenorrhea in 7MM
Table 2: Total Prevalent/Incident Cases of the Dysmenorrhea in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Dysmenorrhea in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Dysmenorrhea in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Dysmenorrhea in United States (2016-2028)*
Table 6: Diagnosed Cases of the Dysmenorrhea in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Dysmenorrhea in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Dysmenorrhea in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Dysmenorrhea in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Dysmenorrhea in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Dysmenorrhea in France (2016-2028)
Table 12: Sub-Type Specific cases of the Dysmenorrhea in France (2016-2028) *
Table 13: Sex- Specific Cases of the Dysmenorrhea in France (2016-2028) *
Table 14: Diagnosed Cases of the Dysmenorrhea in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Dysmenorrhea in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Dysmenorrhea in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Dysmenorrhea in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Dysmenorrhea in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Dysmenorrhea in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Dysmenorrhea in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Dysmenorrhea in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Dysmenorrhea in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Dysmenorrhea in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Dysmenorrhea in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Dysmenorrhea in UK (2016-2028) *
Table 26: Diagnosed Cases of the Dysmenorrhea in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Dysmenorrhea in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Dysmenorrhea in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Dysmenorrhea in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Dysmenorrhea in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Dysmenorrhea in 7MM
Figure 2: Total Prevalent/Incident Cases of the Dysmenorrhea in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Dysmenorrhea in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Dysmenorrhea in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Dysmenorrhea in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Dysmenorrhea in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Dysmenorrhea in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Dysmenorrhea in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Dysmenorrhea in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Dysmenorrhea in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Dysmenorrhea in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Dysmenorrhea in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Dysmenorrhea in France (2016-2028) *
Figure 14: Diagnosed Cases of the Dysmenorrhea in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Dysmenorrhea in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Dysmenorrhea in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Dysmenorrhea in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Dysmenorrhea in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Dysmenorrhea in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Dysmenorrhea in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Dysmenorrhea in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Dysmenorrhea in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Dysmenorrhea in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Dysmenorrhea in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Dysmenorrhea in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Dysmenorrhea in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Dysmenorrhea in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Dysmenorrhea in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Dysmenorrhea in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Dysmenorrhea in Japan (2016-2028)

  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs